Proteon Pharmaceuticals publikuje nowe badania nad strukturą ogonka bakteriofaga
Our researchers have recently published their latest article in Frontiers in Microbiology, a paper titled “Revisiting Phage Tail Spike Architecture: Evidence for Undetected Receptor-Binding Proteins
BAFASAL® otrzymuje autoryzację Unii Europejskiej jako pierwszy zootechniczny dodatek paszowy oparty na bakteriofagach dla drobiu
Proteon Pharmaceuticals is pleased to confirm that BAFASAL®, its pioneering bacteriophage-based feed additive, has received full regulatory approval from the European Union for use in
BAFASAL® coraz bliżej uzyskania autoryzacji na rynku UE
Following the Standing Committee on Plants, Animals, Food and Feed (PAFF Committee) recent meeting in Brussels, Proteon Pharmaceuticals is pleased to share a significant development
Naturalne rozwiązania bakteriofagowe dla wyzwań akwakultury
A 2020 study published in Viruses (MDPI), titled “Growing Trend of Fighting Infections in Aquaculture Environment – Opportunities and Challenges of Phage Therapy”, provides a
Nowatorskie Rozwiązanie w Diagnostyce APEC – Wyniki Badań Naukowych
A team of scientists from Proteon Pharmaceuticals, the Biobank Lodz, and the University of Agriculture in Cracow has developed an innovative method for identifying strains
Proteon Pharmaceuticals uzyskał polski patent na nowe szczepy bakteriofagów stosowanych w akwakulturze
We are excited to announce that our bacteriophage-based technology has been granted patent protection by the Polish Patent Office. The invention, “Bacteriophage strains and their